Literature DB >> 19957447

Localization of enolase in the subfractions of a breast cancer cell line.

Ewa Seweryn1, Jadwiga Pietkiewicz, Iwona S Bednarz-Misa, Ireneusz Ceremuga, Jolanta Saczko, Julita Kulbacka, Andrzej Gamian.   

Abstract

Enolase detected on the cell surface may be a receptor for certain ligands, especially for plasminogen. It is important for the pathogen invasiveness and in the development of a tumour. Therefore, we sought to preliminarily determine the enolase location and catalytic activity in the subfractions of MCF-7 cells. The latter was done on intact cells and in subfractions of MCF-7 cells. We identified enolase by immunoblotting. The binding of human plasminogen to enolase was performed by immunoblotting using monoclonal antibodies against plasminogen. The intact MCF-7 cells demonstrated activity of enolase. Enolase in postnuclear and perinuclear fractions is catalyticly active too. We identified the enolase protein in immunoblots of these fractions, except for the nuclear subfraction. These results provide evidence that enolase is present on the intact surface of MCF-7 cells and in post- and perinuclear fractions. The surface protein maintained catalytic activity, which suggests that its location in the plasma membrane didn't change the active centre of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19957447     DOI: 10.1515/znc-2009-9-1023

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  8 in total

1.  Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells.

Authors:  Lin Yu; Jiandang Shi; Sa Cheng; Yan Zhu; Xiulan Zhao; Kuo Yang; Xiaoling Du; Helmut Klocker; Xiaoli Yang; Ju Zhang
Journal:  Mol Endocrinol       Date:  2012-06-25

2.  STIM1/ORAI1-mediated Ca2+ Influx Regulates Enolase-1 Exteriorization.

Authors:  Miroslava Didiasova; Dariusz Zakrzewicz; Viktor Magdolen; Chandran Nagaraj; Zoltán Bálint; Manfred Rohde; Klaus T Preissner; Malgorzata Wygrecka
Journal:  J Biol Chem       Date:  2015-03-24       Impact factor: 5.157

Review 3.  Plasminogen and its receptors as regulators of cardiovascular inflammatory responses.

Authors:  Riku Das; Elzbieta Pluskota; Edward F Plow
Journal:  Trends Cardiovasc Med       Date:  2010-05       Impact factor: 6.677

4.  Enolase-1 is a therapeutic target in endometrial carcinoma.

Authors:  Mengyang Zhao; Weiyi Fang; Yan Wang; Suiqun Guo; Luyun Shu; Lijing Wang; YiYu Chen; Qiaofen Fu; Yan Liu; Shengni Hua; Yue Fan; Yiyi Liu; Xiaojie Deng; Rongcheng Luo; Zhong Mei; Qinping Jiang; Zhen Liu
Journal:  Oncotarget       Date:  2015-06-20

Review 5.  Gamma-enolase: a well-known tumour marker, with a less-known role in cancer.

Authors:  Tjasa Vizin; Janko Kos
Journal:  Radiol Oncol       Date:  2015-08-21       Impact factor: 2.991

6.  Enolase-like protein present on the outer membrane of Pseudomonas aeruginosa binds plasminogen.

Authors:  Ireneusz Ceremuga; Ewa Seweryn; Iwona Bednarz-Misa; Jadwiga Pietkiewicz; Katarzyna Jermakow; Teresa Banaś; Andrzej Gamian
Journal:  Folia Microbiol (Praha)       Date:  2014-03-27       Impact factor: 2.099

7.  Three are better than one: plasminogen receptors as cancer theranostic targets.

Authors:  Patrizia Ceruti; Moitza Principe; Michela Capello; Paola Cappello; Francesco Novelli
Journal:  Exp Hematol Oncol       Date:  2013-04-17

8.  Anti-α-enolase is a prognostic marker in postoperative lung cancer patients.

Authors:  Kuan-Chung Hsiao; Neng-Yao Shih; Pei-Yi Chu; Yi-Mei Hung; Jia-Yi Liao; Shao-Wen Chou; Yi-Yuan Yang; Gee-Chen Chang; Ko-Jiunn Liu
Journal:  Oncotarget       Date:  2015-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.